PlasmaSelect AG / Disposal 02.07.2008 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- The PlasmaSelect Group today sold and transfered its marketing authorizations, trademarks, export distribution contracts and German inventories related to its product Haemaccel® to the Indian Piramal Healthcare Group. The purchase price amounted to approximately 8 million euros. The PlasmaSelect Group will, for the time being, continue to market in Germany and Italy and to manufacture the product Haemaccel® for Piramal. DGAP 02.07.2008 --------------------------------------------------------------------------- Language: English Issuer: PlasmaSelect AG Pettenkoferstraße 22 80336 München Deutschland Phone: +49 (0)89 810 29-0 Fax: +49 (0)89 810 29-111 E-mail: info@plasmaselect.de Internet: www.plasmaselect.de ISIN: DE0005471809 WKN: 547180 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Stuttgart, München, Hamburg, Düsseldorf End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: PlasmaSelect Group sells its Haemaccel® marketing authorizations
| Source: EQS Group AG